Literature DB >> 28474194

Improving compliance with Intersocietal Accreditation Commission (IAC) reporting standards: A serial comparison of 523 labs over seven years.

P Timothy Maddux1, Mary Beth Farrell2, Joseph A Ewing1, Peter L Tilkemeier1.   

Abstract

BACKGROUND: The aim of this study was to evaluate reporting compliance of laboratories applying for serial accreditation by the Intersocietal Accreditation Commission (IAC) and compare compliance based on laboratory characteristics.
METHODS: All laboratories applying for IAC accreditation for the first time in 2008 and then twice more (2011-2014) were evaluated for compliance with 18 reporting elements. The elements were ranked into three severity groups (high/moderate/low).
RESULTS: Reports from 523 laboratories were evaluated. The percentage of laboratories with reporting issues by cycle was 66.2% for cycle 1, 36.7% for cycle 2, and 43.8% for cycle 3 (p < .001). For most of the 18 elements, there was a significant decrease in the percentage of labs with issues. Less moderate and high severity errors were seen over time. Also, the mean non-compliant elements per laboratory decreased from 5.78 ± 2.72 at cycle 1, down to 1.25 ± 1.77 at cycle 3.
CONCLUSIONS: In facilities applying for 3 consecutive IAC accreditation cycles, reporting compliance with IAC Standards improved between cycles 1-2 and 1-3. No significant improvement occurred between cycles 2-3. Although the quality of reports improved overall, problems remain in quantifying myocardial perfusion defects, documenting report approval date, and integrating stress and imaging reports.

Entities:  

Keywords:  Intersocietal Accreditation Commission; Nuclear cardiology; accreditation; compliance; reporting

Mesh:

Year:  2017        PMID: 28474194     DOI: 10.1007/s12350-017-0904-1

Source DB:  PubMed          Journal:  J Nucl Cardiol        ISSN: 1071-3581            Impact factor:   5.952


  1 in total

1.  Insights into Nuclear Cardiology in the United States from the first 3 years of the ImageGuide Registry.

Authors:  Joshua B Elder; Peter L Tilkemeier; Joseph A Ewing
Journal:  J Nucl Cardiol       Date:  2020-04-27       Impact factor: 5.952

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.